SKI Market

A+| A| A-|

Indian Indices

Sensex

76,808.48 544.15
( 0.71%)

Global Indices

Nasdaq

51,705.57 482.31
(0.94%)

Dow Jones

7,575.20 122.74
(1.65%)

Hang Seng

69,393.70 76.20
(0.11%)

Nikkei 225

10,435.69 -36.03
(-0.34%)

Forex

USD-INR

94.92 -0.57
(-0.60%)

EUR-INR

109.83 -0.42
(-0.38%)

GBP-INR

127.25 -0.49
(-0.38%)

JPY-INR

0.59 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kobo Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

531541

INE881A01015

-55.7880378

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

15.39

EPS(TTM)

Face Value()

Div & Yield %

Back

Board of Elantas Beck India recommends Final Dividend

Feb 24,2026

Elantas Beck India announced that the Board of Directors of the Company at its meeting held on 24 February 2026, has recommended a Final Dividend of Rs.7.50 per share (i.e.75%), subject to the approval of the shareholders.

76,808.48 544.15 ( 0.71%)

51,705.57 482.31 (0.94%)

7,575.20 122.74 (1.65%)

69,393.70 76.20 (0.11%)

10,435.69 -36.03 (-0.34%)

94.92 -0.57 (-0.60%)

109.83 -0.42 (-0.38%)

127.25 -0.49 (-0.38%)

0.59 0.00 (-0.48%)